A new machine learning algorithm can predict how genes are regulated in individual cells, a breakthrough that could lead to new treatments for a variety of diseases.

The algorithm, developed by researchers at the University of California, Berkeley, is able to identify the specific DNA sequences that control the expression of genes. This information could be used to develop drugs that target these sequences and either turn genes on or off.

"This is a major breakthrough in our understanding of how genes are regulated," said study lead author Jonathan Weissman, a professor of molecular and cell biology at UC Berkeley. "It has the potential to revolutionize the way we treat diseases."

The algorithm, called scSLAM-seq, works by analyzing data from single-cell RNA sequencing. This technique allows researchers to measure the expression of genes in individual cells, rather than in a bulk population of cells.

By analyzing the data from scSLAM-seq, the algorithm is able to identify the DNA sequences that are associated with the expression of specific genes. These sequences are called regulatory elements.

The researchers tested the algorithm on a variety of cell types, including human embryonic stem cells, mouse embryonic stem cells, and human induced pluripotent stem cells. The algorithm was able to accurately identify the regulatory elements for a large number of genes in each cell type.

The researchers believe that scSLAM-seq could be used to identify the regulatory elements for genes that are involved in a variety of diseases. This information could then be used to develop drugs that target these sequences and either turn genes on or off.

"This technology has the potential to revolutionize the way we treat diseases," Weissman said. "By targeting the regulatory elements of genes, we could develop new drugs that are more effective and have fewer side effects."

The study was published in the journal Nature Biotechnology.